1. AbCellera (ABCL:NASDAQ) Prepares New Clinical Data Release for Its Oncology Pipeline AbCellera (ABCL:NASDAQ) is expected to issue a clinical‑program …
-
-
CHICAGO, July 14, 2026 — Leads & Copy — Cosmos Health Inc. announced today it has repurchased an additional 133,000 …
-
WALTHAM, Mass. — July 14, 2026 — Leads & Copy — Crescent Biopharma, Inc. announced today that it has begun …
-
ALAMEDA, Calif. — July 14, 2026 — Leads & Copy — Vivani Medical, Inc., a biopharmaceutical company focused on developing …
-
New Product
QIAGEN (NYSE: QGEN) Launches Comprehensive Bloodstream Infection Testing Offering with New CE-IVDR Certified Panel
July 14, 2026 — Leads & Copy — QIAGEN N.V. today announced the launch of the CE-IVDR-certified QIAstat-Dx BCID GN …
-
Top Stories
Noveris Health Sciences Inc. (CSE:NVRS) Joins Life Sciences British Columbia to Enhance Ecosystem Engagement
July 14, 2026 — Leads & Copy — Noveris Health Sciences Inc., a biotechnology company, has joined Life Sciences British …
-
Partner / M&A
Glucotrack, Inc. (Nasdaq: GCTK) and Lōkahi Therapeutics Complete Strategic Business Combination
RUTHERFORD, N.J., La Jolla, Calif. — July 14, 2026 — Leads & Copy — Glucotrack, Inc. (Nasdaq: GCTK) and Lōkahi …
-
EarningsRegulatory
LevelJump Healthcare Corp. (TSXV:JUMP) Reports First Quarter 2026 Financial Results
Toronto, Ontario — July 14, 2026 — Leads & Copy — LevelJump Healthcare Corp. (TSXV: JUMP) has reported its financial …
-
Financings
Crescent Biopharma (Nasdaq:CBIO) Prices Public Offering, Expects $125 Million in Gross Proceeds
WALTHAM, Mass. — July 15, 2026 — Leads & Copy — Crescent Biopharma, Inc. announced the pricing of its underwritten …
-
SOUTH SAN FRANCISCO, Calif. — July 15, 2026 — Leads & Copy — Genentech, a member of the Roche Group, …